Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism RegistryArticle Published on 2022-01-182022-10-28 Journal: Viruses [Category] COVID-19, [키워드] 95% confidence interval accompanied acute respiratory syndrome adenovirus-based Clinical characteristics clinical outcomes controls coronavirus COVID-19 Day major bleeding Moderna Mortality mortality rate mRNA-based not significantly different occur Odds ratio outcome Patient platform Prospective Study recruited registry SARS-CoV-2 selected study outcomes Thromboembolism thrombosis vaccination venous Venous Thromboembolism VTE [DOI] 10.3390/v14020178 PMC 바로가기 [Article Type] Article
Cardiac Adverse Reactions With COVID-19 VaccinationsCardiology Published on 2022-01-182022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Adverse adverse effect cardiac coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines death Emergency use authorization etiology explain Moderna mRNA myocarditis occurred pandemic Pericarditis Pfizer-BioNTech reaction receiving reported required Research second dose the vaccine Vaccine vaccine adverse reaction [DOI] 10.7759/cureus.21372 PMC 바로가기 [Article Type] Cardiology
SARS-CoV-2 Vaccination and Protection Against Clinical Disease: A Retrospective Study, Bouches-du-Rhône District, Southern France, 2021Microbiology Published on 2022-01-182022-10-31 Journal: Frontiers in Microbiology [Category] COVID-19, [키워드] Against age breakpoint circulating clinical Complete Complication COVID-19 COVID-19 vaccine death died District dose Effectiveness exhibited form France Hospitalization ICU infecting injection intensive care Marseille Moderna Mortality Most patient occur Patient patients Pfizer-BioNTech Pfizer/BioNTech Post-vaccine Prevent protection protective effect provided required risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant significantly more single dose tested transfer vaccinal vaccination Vaccine vaccine doses Vaccines variant variants [DOI] 10.3389/fmicb.2021.796807 PMC 바로가기 [Article Type] Microbiology
IgG and IgA Antibodies Post SARS-CoV-2 Vaccine in the Breast Milk and Sera of Breastfeeding WomenArticle Published on 2022-01-162022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] absence Analysis anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG antibodies Astra Zeneca average Breast breast milk Breastfeeding carried changes in collected Complete COVID-19 COVID-19 pandemic decrease enrolled evaluate expected Fever first dose Health Health status IgA IgG IgG antibody immunological characteristics Infant information Intervention milk mitigate Moderna mother Neutralizing pandemic persistence Pfizer/BioNTech positive SARS-CoV-2 second dose sera serum Seven vaccination vaccination against COVID-19 Vaccine vaccine dose women [DOI] 10.3390/vaccines10010125 PMC 바로가기 [Article Type] Article
High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals이전에 감염된 개인의 백신 유도 항체에 의한 Mu 및 C.1.2 SARS-CoV-2 변이체의 고역가 중화Article Published on 2022-01-112022-09-11 Journal: Cell Reports [Category] SARS, 변종, 진단, [키워드] ACE2 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Ad26 Ad26.COV2.S angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 antibodies antibody Antibody titers avidity BNT162b2 C.1.2 convalescent individual convalescent individuals coronavirus COV2.S COVID-19 decrease disease fitness high affinity humoral Humoral response individual infected individual Infection less Moderna Moderna mRNA-1273 mRNA Mu mutated Mutation neutralization neutralize Neutralizing antibodies neutralizing antibody Neutralizing antibody titer neutralizing antibody titers Pfizer Pfizer BNT162b2 rationale respiratory SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant sera severe acute respiratory syndrome Coronavirus Spike protein Spike proteins the spike protein titers vaccinated individual vaccinated individuals vaccination Vaccine variant variants virus viruses [DOI] 10.1016/j.celrep.2021.110237 PMC 바로가기 [Article Type] Article
Evaluation of Transplacental Antibody Transfer in SARS-CoV-2-Immunized Pregnant WomenArticle Published on 2022-01-102022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acute respiratory syndrome antibody antibody transfer B.1.617.2 Blood clinical cohort study conducted Cord blood coronavirus COVID-19 COVID-19 vaccine Delta delta variant dose effective evaluated highlight IgG antibody immune response immunization indicate Infection maternal immunity median Moderna mother mRNA vaccination mRNA-1273 Neonatal neutralizing antibody Newborn outcome Pregnancy pregnant women Receptor binding domain reduction SARS-CoV-2 sera subsequent Support Transplacental vaccination Vaccine variant wildtype women [DOI] 10.3390/vaccines10010101 PMC 바로가기 [Article Type] Article
Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S VaccinesArticle Published on 2022-01-102022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Ad26.COV2.S age analyzed anti-SARS-CoV-2 antibody antibodies antibody Blood Blood Group cellular response ChAdOx1 comparable comparison Concentration convalescent correlation COVID-19 COVID-19 vaccine enzyme Gender highest humoral IgG IgG antibodies IgG antibody IgG antibody titer immune system immunoassay induce Janssen/Johnson & Johnson levels of antibodies material Moderna mRNA mRNA vaccine mRNA vaccines mRNA-1273 nCOV-2019 Nicolaus Copernicus of BNT162b2 Oxford/AstraZeneca parameter Participants Pfizer/BioNTech produced SARS-CoV-2 SARS-COV-2 infection serum sample significant difference stability statistical analysis the vaccine university vaccination Vaccines [DOI] 10.3390/vaccines10010099 PMC 바로가기 [Article Type] Article
Initial Mix-and-Match COVID-19 Vaccination Perceptions, Concerns, and Side Effects across CanadiansArticle Published on 2022-01-092022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] adenoviral vector adenoviral vector vaccine Canadian Combination coronavirus COVID-19 COVID-19 vaccine demographic characteristics dose Effect first dose highest immune response implication indicate individual initial Moderna mRNA mRNA vaccine Oxford-AstraZeneca participant perceptions Pfizer-BioNTech Psychological Research Result second dose side Side effect Side effects Vaccine vaccine concerns vaccine dose vaccine side effects [DOI] 10.3390/vaccines10010093 PMC 바로가기 [Article Type] Article
A new testing platform using fingerstick blood for quantitative antibody response evaluation after SARS-CoV-2 vaccinationSARS-CoV-2 백신 접종 후 정량적 항체 반응 평가를 위한 손가락 채혈을 이용한 새로운 검사 플랫폼Coronaviruses Published on 2022-01-072022-09-10 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료법, [키워드] 95% CI addition agreement analyzed anti-SARS-CoV-2 anti-SARS-CoV-2 IgG anti-SARS-CoV-2 S1 IgG antibody Antibody Response Antibody testing blood plasma blood sample collected combating component correlated COVID-19 pandemic COVID19 described detected antibody Efficacy evaluated feasibility fingerstick fingerstick blood healthy IgG antibody limit linear Moderna mRNA mRNA vaccine negative neutralization test nucleocapsid Participants Pfizer plaque reduction neutralization Plaque reduction neutralization test platform PRNT Protein quantification Quantitative quantitative immunoassay. SARS-CoV-2 vaccination receiving S1 IgG SARS-CoV-2 SARS-CoV-2 vaccination spike IgG responses Testing vaccinated individuals vaccination vaccine dose vaccine-induced antibodies venous venous blood Volunteer [DOI] 10.1080/22221751.2021.2023328 PMC 바로가기 [Article Type] Coronaviruses
Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 VaccinesArticle Published on 2022-01-042022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] administer age booster vaccination Cambridge COVID-19 demonstrated dose health-care individual Infection infection with SARS-CoV-2 Mainz Mild symptom Moderna mRNA vaccine mRNA-based neutralization titer neutralization/neutralisation neutralizing responses Neutralizing titer neutralizing titers neutralizing/neutralising antibodies Oxford-AstraZeneca regimen regimens SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-infected individual single dose titer USA vaccination Vaccine vector vaccine were assessed were infected worker York [DOI] 10.3390/vaccines10010075 PMC 바로가기 [Article Type] Article